Preview

Obstetrics, Gynecology and Reproduction

Advanced search

PRINCIPLES OF PREVENTIVE THERAPY IN PREGNANT WOMEN WITH METABOLIC SYNDROME

https://doi.org/10.17749/2070-4968.2015.9.4.036-045

Full Text:

Abstract

Metabolic syndrome is widespread among women of reproductive age. Metabolic syndrome is associated with at higher risk of developing various obstetric complications. The hereditary or acquired forms of thrombophilia may play an important role in impaired invasion cytotrophoblast and impaired placental development. It may lead to fetal loss syndrome, pre-eclampsia, intrauterine growth retardation and other obstetric complications in women with metabolic syndrome The earlier antithrombotic prophylaxis is initiated, the better the outcome of pregnancy will be.

About the Authors

E. B. Perederyaeva
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
PhD of medical sciences, Senior Researcher


T. B. Pshenichnikova
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
PhD of medical sciences, Senior Researcher


A. D. Makatsariya
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
MD, corresponding member of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics and Gynecology


References

1. Belotserkovtseva L.D., Kovalenko L.V., Korneeva E.V. et al. Features of the metabolic syndrome in women in different periods of life: pathogenesis, clinical features, diagnosis, treatment [Osobennosti metabolicheskogo sindroma u zhenshchin v razlichnye periody zhizni: patogenez, klinika, diagnostika, lechenie (In Russian)]. Moscow. 2010. 73 s.

2. Berikhanova R.R. Features of pregnancy, childbirth, postpartum patients with metabolic syndrome. PhD. Diss. [Osobennosti techeniya beremennosti, rodov, poslerodovogo perioda u patsientok s metabolicheskim sindromom (In Russian)]. Volgograd. 2009; 166 s.

3. Borovkova E.I. The management of pregnancy in patients with overweight and obesity. The materials of the educational seminar "Women's reproductive health is during pregnancy" [Vedenie beremennosti u patsientov s izbytochnym vesom i ozhireniem. Materialy obrazovatel'nogo seminara «Reproduktivnoe zdorov'e zhenshchin vne i vo vremya beremennosti (In Russian)]. Moscow. 2010; 23-27.

4. Borovkova E.I. Management of pregnant women with obesity and metabolic syndrome. Dr. diss. [Taktika vedeniya beremennykh s ozhireniem i metabolicheskim sindromom (In Russian)]. Moscow. 2013; 48 s.

5. Burumkulova F.F., Petrukhin V.A., Kovalenko T.S., Titova T.V., Golovchenko M.A. Gestational diabetes – an interdisciplinary problem. Proceedings of the X jubilee All- Russia. Scientific Forum "Mother and Child" [Gestatsionnyi sakharnyi diabet – mezhdistsiplinarnaya problema. Materialy X yubileinogo Vseross. nauchnogo foruma «Mat' i ditya»(In Russian)]. Moscow. 2009; 30-31.

6. Gadaeva Z.K. The frequency and spectrum of polymorphisms of proinflammatory cytokines and thrombophilia in women with metabolic syndrome and preeclampsia. Proceedings of the X jubilee All-Russian Scientific Forum "Mother and Child" [Chastota i spektr polimorfizmov provospalitel'nykh tsitokinov i trombofilii u beremennykh s metabolicheskim sindromom i gestozom. Materialy X yubileinogo Vserossiiskogo nauchnogo foruma «Mat' I Ditya» (In Russian)]. Moscow. 2009; 42.

7. Gorokhova L.G. Dynamics of lipid and carbohydrate metabolism in the mother – fetus – newborn obesity in women [Dinamika obmena uglevodov i lipidov v sisteme mat' – plod – novorozhdennyi pri ozhirenii u zhenshchin (In Russian)]. Irkutsk. 1995; 19 s.

8. Dedov I.I., Mel'nichenko G.A. Obesity. Etiology, pathogenesis, clinical aspects [Ozhirenie. Etiologiya, patogenez, klinicheskie aspekty (In Russian)]. Moscow. 2004; 216-232.

9. Dmitriev A.N. Obesity and metabolic syndrome [Ozhirenie i metabolicheskii sindrom (In Russian)]. Ekaterinburg. 2001.

10. Erchenko E.N. The pathophysiological features of carbohydrate and lipid metabolism and neonatal status in pregnant women with overweight and obesity. PhD. Diss. [Patofiziologicheskie osobennosti uglevodnogo i lipidnogo obmenov i sostoyanie novorozhdennykh u beremennykh s izbytochnoi massoi tela I ozhireniem (In Russian)]. Moscow. 2009; 28 s.

11. Ivashkin V.T., Drapkina O.M., Korneeva O.N. Clinical variants of metabolic syndrome [Klinicheskie varianty metabolicheskogo sindroma (In Russian)]. Moscow. 2011; 220 s.

12. Kuzin A.I., Lengin Yu.A. Metabolic syndrome: clinical and population issues [Metabolicheskii sindrom: klinicheskie i populyatsionnye aspekty (In Russian)]. Chelyabinsk. 2001.

13. Kuz'mina-Krutetskaya S.R., Repina M.A. Metabolic syndrome in women [Metabolicheskii sindrom u zhenshchin (In Russian)]. Spb. 2011; 76 s.

14. Makarov I.O., Shilov E.M., Petunina N.A et. al. Rossiiskii vestnik akushera-ginekologa. 2012; 3: 36-41.

15. Makatsariya A.D., Perederyaeva E.B., Pshenichnikova T.B. Consilium-medicum. 2006; 8 (6): 35-41.

16. Makatsariya A.D., Perederyaeva E.B., Pshenichnikova T.B. Vrach. 2007; 12: 41-45.

17. Makatsariya A.D., Perederyaeva E.B., Pshenichnikova T.B. Zhurnal rossiiskogo obshchestva akusherov-ginekologov. 2007; 3: 11-16.

18. Makolkin V.I. Metabolic syndrome [Metabolicheskii sindrom (In Russian)]. Moscow. 2010; 144 s.

19. Mamedov M.N. Components of the metabolic syndrome in patients with hypertension [Komponenty metabolicheskogo sindroma u bol'nykh s arterial'noi gipertoniei (In Russian)]. Moscow. 1997; 100 s.

20. Metabolic syndrome and thrombophilia in obstetrics and gynecology / A.D. Makatsariya, E.B. Pshenichnikova, T.B. Pshenichnikova, V.O. Bitsadze [Metabolicheskii sindrom i trombofiliya v akusherstve i ginekologii (In Russian)]. Moscow. 2006; 480 s.

21. Mochalov A.A., Sokolov E.I., Manukhin I.B. Lechashchii vrach. 2011; 3: 43-47.

22. Mychka V.B., Chazova I.E. Meditsina. Kachestvo zhizni. 2005; 3 (10): 28-33.

23. Obesity. Guide for physicians. Edited NA Belyakov, VI Mazurova [Ozhirenie. Rukovodstvo dlya vrachei. Pod redaktsiei N.A. Belyakova, V.I. Mazurov (In Russian)]. SPb. 2003; 96-119, 219-234.

24. Perederyaeva E.B. The basic principles of management of pregnancy and safe delivery in women with metabolic syndrome PhD. Diss. [Osnovnye printsipy vedeniya beremennosti i bezopasnogo rodorazresheniya u zhenshchin s metabolicheskim sindromom (In Russian)]. Moscow. 2006; 149 s.

25. Perederyaeva E.B., Pshenichnikova T.B. Prakticheskaya meditsina. 2013; 7 (76): 34-45.

26. Perederyaeva E.B., Pshenichnikova T.B., Donina E.V., Makatsariya A.D., Kapanadze D.L. Akusherstvo, ginekologiya i reproduktsiya / Obstetrics, gynecology and reproduction. 2014; 1: 60-67.

27. Pshenichnikova T.B., Pshenichnikova E.B. Akusherstvo i ginekologiya. 2006; 5: 29-32.

28. Pshenichnikova E.B., Pshenichnikova T.B., Makatsariya A.D. Akusherstvo i ginekologiya. 2006; 4: 15-19.

29. Pshenichnikova T.B., Perederyaeva E.B, Donina E.V., Gadaeva Z.K. Akusherstvo, ginekologiya i reproduktsiya / Obstetrics, gynecology and reproduction. 2013; 4: 35-43.

30. Sarkisova A.V. The course of pregnancy and childbirth in women with metabolic syndrome. PhD. Diss. [Techenie beremennosti i rodov u zhenshchin s metabolicheskim sindromom. (In Russian)]. Moscow. 2004; 85 s.

31. Semikhnenko I.N. The clinical significance of vitamin imbalances in patients with metabolic syndrome. PhD. Diss. [Klinicheskoe znachenie vitaminnogo disbalansa u bol'nykh s metabolicheskim sindromom (In Russian)]. nauk. Tyumen'. 2003; 30.

32. Strizhakov A.N., Davydov A.I., Lebedev V.A., Ignatko I.V., Makatsariya A.D., Mezhevitinova E.A., Perederyaeva E.B., Pshenichnikova T.B., Tetruashvili N.K., Shakhlamova M.N. Voprosy ginekologii, akusherstva i perinatologii. 2009; 8 (3): 5-18.

33. AACE Position Statement on Insulin Resistance Syndrome. ACE Guidelines for Glycemic Control. Endocrine Practice. 2003; 9 (1): 7-19.

34. AACE Position Statement on Insulin Resistance Syndrome. ACE Guidelines for Glycemic Control. Endocrine Practice. 2003; 9 (1): 7-19.

35. Aldhahi W., Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep. 2003 Aug; 3 (4): 293-8.

36. Andersen P. Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome. J Cardiovasc Pharmacol. 1992; 20 (8): 29-31.

37. Aso Y., Wakabayashi S., Yamamoto R. et al. Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor- 1 and thrombin-activatable fibrinolysis inhibitor. Diabetes Care. 2005 Sep; 28 (9): 2211-6.

38. Barker D.J. Maternal nutrition, fetal nutrition, and disease in later life. Nutrition. 1997 Sep; 13 (9): 807-13.

39. Boucher B.J. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? Br J Nutr. 1998 Apr; 79 (4): 315-27.

40. Chiu K.C., Chu A., Go V.L. et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004 May; 79 (5): 820-5.

41. Dimova E.Y., Samoylenko A., Kietzmann T. Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid Redox Signal. 2004 Aug; 6 (4): 777-91.

42. Eckel Robert H. Obesity: mechanisms and clinical management. Philadelphia. Lippincott Williams And Wilkins. 2003; 378-398.

43. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Program (NOEP). Expert Panel on detection, evaluation and Treatment of high blood Cholesterol in Adults (Adult Treatment Panel III). SAMA. 2001; 285: 248-49.

44. Festa A., D'Agostino R. Jr., Tracy R.P., Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes. 2002; 51: 1131-1137.

45. Guerrero-Romero F., Rodrigues-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol. 2002 Dec; 39 (4): 209-13.

46. Hoekstra T., Geleijnse J.M., Schouten E.G. et al. Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly. Nutr Metab Cardiovasc Dis. 2005 Aug; 15 (4): 270-8.

47. Kaplan N.M. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med. 1989; 149: 1514-1520.

48. Reaven G., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympatoadrenal system. N Engl J Med. 1996; 334: 374-381.

49. Shaw G.M., Velie E.M., Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA. 1996 Apr 10; 275 (14): 1127-8.

50. Takaya J., Higashino H., Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res. 2004 Jun; 17 (2): 126-36.

51.

52.


For citation:


Perederyaeva E.B., Pshenichnikova T.B., Makatsariya A.D. PRINCIPLES OF PREVENTIVE THERAPY IN PREGNANT WOMEN WITH METABOLIC SYNDROME. Obstetrics, Gynecology and Reproduction. 2015;9(4):36-45. (In Russ.) https://doi.org/10.17749/2070-4968.2015.9.4.036-045

Views: 61


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)